Discover the latest financial disclosures from Anebulo Pharmaceuticals, Inc. in their 8-K report, filed February 20, 2025. Key metrics and compliance insights included.
Explore Anebulo Pharmaceuticals' recent Form 8-K filing detailing significant announcements, stock metrics, and financial insights as of February 14, 2025.
Explore Anebulo Pharmaceuticals' latest financial report detailing a $4.7M net loss, funding updates, and investment recommendations amidst regulatory challenges.
Discover Anebulo Pharmaceuticals' latest 8-K filing from February 11, 2025, detailing significant corporate events impacting ANEB stock. Stay informed on crucial developments!
Discover essential insights from Anebulo Pharmaceuticals' 8-K report filed on December 22, 2024. Stay informed about stock performance, financial updates, and key company changes.